Short Interest in Elekta AB (publ) (OTCMKTS:EKTAY) Increases By 300.0%

Elekta AB (publ) (OTCMKTS:EKTAY) was the target of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 400 shares, a growth of 300.0% from the February 28th total of 100 shares. Based on an average trading volume of 22,500 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company’s shares are short sold.

Analyst Upgrades and Downgrades

Separately, Sanford C. Bernstein raised shares of Elekta AB (publ) from a “strong sell” rating to a “hold” rating in a research note on Wednesday, January 29th.

Elekta AB (publ) Trading Down 0.7 %

OTCMKTS EKTAY traded down $0.04 during trading on Friday, hitting $5.34. The stock had a trading volume of 16,185 shares, compared to its average volume of 9,649. The company has a quick ratio of 0.81, a current ratio of 1.05 and a debt-to-equity ratio of 0.60. The company has a market capitalization of $2.05 billion, a PE ratio of 21.35 and a beta of 1.25. The firm has a 50 day moving average price of $5.76 and a 200 day moving average price of $5.93. Elekta AB has a twelve month low of $5.25 and a twelve month high of $8.24.

Elekta AB (publ) (OTCMKTS:EKTAY) last announced its earnings results on Friday, February 21st. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.01). The business had revenue of $416.86 million for the quarter, compared to analysts’ expectations of $435.89 million. Elekta AB (publ) had a return on equity of 11.07% and a net margin of 5.65%. As a group, equities research analysts forecast that Elekta AB will post 0.36 earnings per share for the current year.

Elekta AB (publ) Cuts Dividend

The company also recently declared a dividend, which was paid on Thursday, March 27th. Shareholders of record on Friday, March 7th were issued a dividend of $0.1072 per share. The ex-dividend date of this dividend was Friday, March 7th. Elekta AB (publ)’s dividend payout ratio (DPR) is presently 44.00%.

Elekta AB (publ) Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.